Menu

EMAP
Grup d’Estudis de Medicament en Atenció Primària (EMAP)

Group leader
40882722S - Rosa Morros Pedrós - OK retall
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Projects

Group projects

Safety of Paxlovid among patients with moderate or severe hepatic or renal impairment (C4671047, VAC4EU & SIGMA study)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00182-23
  • Start year: 2023
  • Funders: Research Triangle Institute (RTI)

Study protocol for the Teratogenic Drugs Prioritisation (TDP) project combining pre-clinical data with clinical data from ConcePTION data sources (task 7.9)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00095-24
  • Start year: 2024

A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4RNC-0-00211-24
  • Start year: 2024
  • Funders: European Medicines Agency (EMA)

Antiseizure meDication Exposure and Pregnancy and neonaTal outcomes research (ADEPT). Use of antiepileptics, and feasibility of studies on the association between maternal and paternal exposure to antiepileptics and adverse pregnancy, neonatal and child outcomes

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4RNC-0-00239-24
  • Start year: 2024
  • Funders: European Medicines Agency (EMA)

Impact of medication adherence on mortality and cardiovascular morbidity: a population-based retrospective cohort study. IMPACT study

  • Principal investigators: Maria Giner Soriano
  • Code: 4R17/020
  • Start year: 2017
  • Funders: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)

Board of Trustees

Collaborators

Accreditations